Study Finds Many GLP-1 Patients Quit Too Early For Benefits

WASHINGTON (dpa-AFX) - A study by the Blue Cross Blue Shield Association discovered that more than half of individuals prescribed GLP-1 medications such as Saxenda and Wegovy for weight loss in

Related Keywords

Washington ,United States ,Razia Hashmi ,James Gelfand ,Blue Cross Shield Association ,Industry Committee ,Blue Cross Shield ,Ihr Portfolio ,